Table 1 Demonstration of Aspirin non-Compliance by Repeat Testing
| Â | Â | Methods for | Â | |
|---|---|---|---|---|
N | % non-Compliant | ASA Effect | Repeat Testing for Compliance After | Reference |
192 | 9.0 | AA Light Aggregometry | Observed ASA ingestion | [24] |
212 | 14.0 | PFA-100 | Strict reinforcement of compliance | [27] |
203 | 3.4 | Thromboelastography | Hospitalization | [26] |
73 | 16.0 | Thromboxane B2: plasma | Admitted to non-compliance | [28] |
87 | 20.0 | Collagen Light Aggregometry | Admitted to non-compliance | [29] |
678 | 2.0 | AA light Aggregometry | Ex vivo ASA | [25] |